214 related articles for article (PubMed ID: 9032273)
1. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins.
Spotts GD; Patel SV; Xiao Q; Hann SR
Mol Cell Biol; 1997 Mar; 17(3):1459-68. PubMed ID: 9032273
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein.
Blackwood EM; Lugo TG; Kretzner L; King MW; Street AJ; Witte ON; Eisenman RN
Mol Biol Cell; 1994 May; 5(5):597-609. PubMed ID: 7919540
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
Smith-Sørensen B; Hijmans EM; Beijersbergen RL; Bernards R
J Biol Chem; 1996 Mar; 271(10):5513-8. PubMed ID: 8621409
[TBL] [Abstract][Full Text] [Related]
4. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
Hann SR; Dixit M; Sears RC; Sealy L
Genes Dev; 1994 Oct; 8(20):2441-52. PubMed ID: 7958908
[TBL] [Abstract][Full Text] [Related]
5. Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.
Sato K; Masuda T; Hu Q; Tobo T; Gillaspie S; Niida A; Thornton M; Kuroda Y; Eguchi H; Nakagawa T; Asano K; Mimori K
EBioMedicine; 2019 Jun; 44():387-402. PubMed ID: 31175057
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding.
McEwan IJ; Dahlman-Wright K; Ford J; Wright AP
Biochemistry; 1996 Jul; 35(29):9584-93. PubMed ID: 8755740
[TBL] [Abstract][Full Text] [Related]
7. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
Arsura M; Deshpande A; Hann SR; Sonenshein GE
Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
[TBL] [Abstract][Full Text] [Related]
8. Methionine deprivation regulates the translation of functionally-distinct c-Myc proteins.
Hann SR
Adv Exp Med Biol; 1995; 375():107-16. PubMed ID: 7645422
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.
Henriksson M; Bakardjiev A; Klein G; Lüscher B
Oncogene; 1993 Dec; 8(12):3199-209. PubMed ID: 8247524
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.
Farina A; Faiola F; Martinez E
Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254
[TBL] [Abstract][Full Text] [Related]
11. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain.
Hoang AT; Lutterbach B; Lewis BC; Yano T; Chou TY; Barrett JF; Raffeld M; Hann SR; Dang CV
Mol Cell Biol; 1995 Aug; 15(8):4031-42. PubMed ID: 7623799
[TBL] [Abstract][Full Text] [Related]
12. B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation.
Gregory MA; Xiao Q; Cornwall GA; Lutterbach B; Hann SR
Oncogene; 2000 Oct; 19(42):4886-95. PubMed ID: 11039906
[TBL] [Abstract][Full Text] [Related]
13. Internal ribosome entry segment-mediated initiation of c-Myc protein synthesis following genotoxic stress.
Subkhankulova T; Mitchell SA; Willis AE
Biochem J; 2001 Oct; 359(Pt 1):183-92. PubMed ID: 11563982
[TBL] [Abstract][Full Text] [Related]
14. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas.
Hann SR; King MW; Bentley DL; Anderson CW; Eisenman RN
Cell; 1988 Jan; 52(2):185-95. PubMed ID: 3277717
[TBL] [Abstract][Full Text] [Related]
15. AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC.
Taira T; Maëda J; Onishi T; Kitaura H; Yoshida S; Kato H; Ikeda M; Tamai K; Iguchi-Ariga SM; Ariga H
Genes Cells; 1998 Aug; 3(8):549-65. PubMed ID: 9797456
[TBL] [Abstract][Full Text] [Related]
16. Binding and suppression of the Myc transcriptional activation domain by p107.
Gu W; Bhatia K; Magrath IT; Dang CV; Dalla-Favera R
Science; 1994 Apr; 264(5156):251-4. PubMed ID: 8146655
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
Park S; Hahm ER; Lee DK; Yang CH
J Cell Biochem; 2004 Apr; 91(5):973-86. PubMed ID: 15034932
[TBL] [Abstract][Full Text] [Related]
18. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.
Albert T; Urlbauer B; Kohlhuber F; Hammersen B; Eick D
Oncogene; 1994 Mar; 9(3):759-63. PubMed ID: 8108117
[TBL] [Abstract][Full Text] [Related]
19. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
20. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
Barrett J; Birrer MJ; Kato GJ; Dosaka-Akita H; Dang CV
Mol Cell Biol; 1992 Jul; 12(7):3130-7. PubMed ID: 1620120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]